Parexel International

PAREXEL International Corporation is a biopharmaceutical services company that supports the pharmaceutical, biotechnology, and medical device industries globally. Founded in 1983 and headquartered in Waltham, Massachusetts, PAREXEL offers a wide range of services through three main segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics. The CRS segment specializes in managing clinical trials, including study design, patient enrollment, data management, and pharmacovigilance. The PCMS segment provides consulting services in drug development, regulatory affairs, and market access, assisting clients with product launch strategies and reimbursement issues. Additionally, the Perceptive segment offers technology solutions such as medical imaging, data management systems, and patient engagement applications. By delivering comprehensive expertise in clinical research and commercialization, PAREXEL facilitates scientific discoveries and the development of new treatments.

23 past transactions

Roam Analytics

Acquisition in 2020
Roam Analytics is a healthcare technology company that specializes in transforming the analysis of patient and provider pathways through its innovative machine learning platform. The company’s flagship offering, the Roam Health Knowledge Graph, organizes healthcare entities—such as drugs, devices, diseases, and providers—based on meaningful relationships derived from a variety of public data sources. This structured data ontology facilitates the integration of new structured and unstructured datasets, creating a comprehensive asset that enhances the visibility of the healthcare landscape. By leveraging advanced natural language processing capabilities, Roam enables healthcare organizations to extract actionable insights from language data, ultimately supporting improved decision-making in development, marketing, and outreach across diverse therapeutic areas.

The Medical Affairs Company

Acquisition in 2017
The Medical Affairs Company LLC, based in Kennesaw, Georgia, is a contract medical organization specializing in medical and scientific affairs solutions for the pharmaceutical, biotechnology, and medical device industries. Founded in 2007, the company offers a range of services, including contract and consultative medical science liaison (MSL) programs, MSL training and reporting systems, and medical communications support. It also provides tools such as mslConnect, which facilitates communication between MSLs and their stakeholders, and i-MSL, a web-based conferencing solution for clinical consultations. Additionally, The Medical Affairs Company delivers peer-to-peer scientific interaction, pharmacovigilance, medical writing, and support for medical meetings. With approximately 200 employees, the organization aims to meet the strategic and tactical needs of its clients while enhancing the efficiency of medical affairs teams.

ExecuPharm

Acquisition in 2016
ExecuPharm Inc. is a functional service contract research organization (CRO) based in King of Prussia, Pennsylvania, with a global presence in regions including North America, South America, Europe, and Asia. Founded in 1995, the company specializes in providing comprehensive clinical research support services to the biopharmaceutical industry. Its offerings encompass a wide range of functional services, including clinical trial management, monitoring, site management, document management, regulatory compliance, and vendor oversight. ExecuPharm employs a flexible business model that integrates advanced technologies and tailored service solutions to effectively address the complexities of clinical trials. With a strong emphasis on staffing, its network comprises over 15,000 clinical operational specialists, many of whom possess extensive industry experience. The company is noted for its high rates of talent acquisition and retention, as well as its ability to deploy project team resources quickly. Additionally, ExecuPharm is certified by the Women’s Business Enterprise National Council, reflecting its commitment to diversity and inclusion in business practices.

Health Advances

Acquisition in 2016
Health Advances, LLC is a strategy consulting firm that specializes in the healthcare industry, providing comprehensive consulting services to pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as their investors. Founded in 1992 and headquartered in Weston, Massachusetts, with additional offices in Boston, San Francisco, Washington, D.C., and Zug, Switzerland, the firm offers a diverse range of services. These include the development of commercialization strategies, clinical development strategy, due diligence, market assessment and forecasting, lifecycle management, and technology commercialization. Health Advances focuses on various therapeutic areas such as autoimmune diseases, oncology, cardiology, and infectious diseases, among others. The firm leverages analytics and insights to deliver tailored solutions that facilitate clients' success in navigating the complex healthcare landscape.

Quantum Solutions India

Acquisition in 2015
Quantum Solutions India is a contract research organization established in 2004 and based in Chandigarh, India, specializing in drug safety services for the global pharmaceutical industry. The company offers a comprehensive range of pharmacovigilance services, including the processing of individual case safety reports, aggregate report writing, signal detection, and affiliate support. In addition, Quantum Solutions provides medical writing programs, which encompass safety narratives, risk management plans, clinical study protocols, and patient-related documentation. It also conducts literature searches and reviews for inclusion in safety reports and other specialized documents. Serving clients in pharmaceutical, medical device, and consumer sectors, the company operates across various therapeutic areas, including oncology, dermatology, and immunology. With a workforce of approximately 900 employees, Quantum Solutions India is positioned to support drug safety and regulatory compliance for its clients worldwide.

ClinIntel

Acquisition in 2014
ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel was founded in 2009, and works with biopharmaceutical companies and contract research organizations.

ATLAS Medical Services

Acquisition in 2014
ATLAS provides services across all phases of clinical development and has therapeutic expertise in Oncology, Hematology, Endocrinology, Cardiovascular, Anesthesiology, Infectious Diseases and the Central Nervous System. The firm also provides clinical trial-related services from study planning and feasibility, through site selection, data management and medical writing. ATLAS also provides regulatory services and can support product registration. - See more at: https://www.parexel.com/organization/news-events/press-releases/2014/parexel-international-announces-acquisition-atlas-medical-services-provider-clinical-research-services-turkey#sthash.mKquI29x.dpuf

HERON Group

Acquisition in 2013
HERON Group LTD (“HERON”) is a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. HERON has expertise and methodologies spanning a wide range of services, including strategic market access planning, systematic reviews, economic modeling and evaluation, pricing, reimbursement strategies, global value dossier writing, and engagement with Health Technology Assessment authorities.

Liquent

Acquisition in 2012
Founded in 1994 and headquartered in Fort Washington, Pennsylvania, Liquent provides content assembly and publishing solutions for the life sciences industry. Its offerings include CoreDossier, kPublisher, kPortal, Liquent Xtent, and ExSource Solution, serving pharmaceutical manufacturers, biotechnology companies, and other related industries.

ClinPhone

Acquisition in 2008
ClinPhone is a clinical technology organization headquartered in Nottingham, United Kingdom. The company specializes in developing integrated telephone and web-based systems designed to enhance the quality and cost-effectiveness of data capture and transfer during clinical trials. By providing innovative solutions for pharmaceutical and biotechnology companies, ClinPhone plays a critical role in streamlining the clinical trial process, ensuring accurate data management and improving overall trial efficiency.

PAREXEL APEX International Co.

Acquisition in 2007
APEX International Clinical Research Co., Ltd. (“APEX”). APEX providing clients with a wide range of clinical research service offerings throughout the Asia-Pacific region, including mainland China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia.

California Clinical Trials Medical Group

Acquisition in 2006
California Clinical Trials Medical Group, Inc. (“CCT”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.

Behavioral and Medical Research

Acquisition in 2006
Behavioral and Medical Research, LLC (“BMR”). Established in 1981 with headquarters in San Diego, provide a broad range of specialty Phase I – IV clinical research services through four clinical sites in California.

Perceptive Informatics

Acquisition in 2005
Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak.

QdotPharma

Acquisition in 2005
QdotPharma is a clinical pharmacology company based in George, South Africa, specializing in Phase I and IIa Proof of Concept studies. Founded in 1996, it operates 32 beds and focuses on developing treatments for a variety of medical conditions, including central nervous system disorders, psychiatric issues, cardiovascular diseases, and metabolic conditions. The company provides a range of clinical research services to the pharmaceutical industry, including clinical studies, investigator services, contract research organization (CRO) functions, site management organization (SMO) services, and data management.

Integrated Marketing Concepts

Acquisition in 2004
Integrated Marketing Concepts specializes in clinical trial patient recruitment and retention, sales lead management, teleservices, call center services, fulfillment, focus group and database management, and market research. IMC serves a diversified client base across a wide array of industries, including pharmaceutical and biotechnology companies, and drug manufacturers. The Company employs approximately 50 individuals at its headquarters in Whitehall, PA.

3ClinicalResearch AG

Acquisition in 2004
3ClinicalResearch AG (“3C”) is a clinical research organization. The privately held company based in Berlin, Germany.

FW Pharma Systems

Acquisition in 2003
FW Pharma Systems Ltd., is a software company that delivers enterprise-wide clinical trial management systems (CTMS). The privately held company is based in Birmingham, United Kingdom.

Pracon & HealthIQ

Acquisition in 2002
Pracon & HealthIQ provides services to pharmaceutical, biotech, and medical device companies in the areas of reimbursement assistance services, communications, and competitive intelligence. Founded in 1976.

Invantage

Acquisition in 2002
Established in 1994, Invantage has focused on the development of solutions that expedite clinical study start-up via a portfolio of advanced software applications and associated services. Invantage’s flagship product, the Investigator DataWeb Enterprise Edition, is a sophisticated web-based data repository of potential clinical investigators combined with a decision support environment for initiating clinical trials. The product was developed in conjunction with a number of major pharmaceutical companies.

EDYABE

Acquisition in 2001
EDYABE is a clinical research organization in Latin America located in Argentina and Brazil.

FARMOVS PAREXEL (Proprietary)

Acquisition in 2000
FARMOVS-PAREXEL is an established pharmacology research unit and bioanalytical laboratory dedicated to performing clinical pharmacology studies. Trials conducted at this unit include, but are not limited to, proof-of-concept, drug interaction, single and multiple dose, specialized PK/PD and biomarker, glucose clamp, spiro-ergometry, and recombinant vaccine studies. It is a part of the PAREXEL Clinical Pharmacology Network that includes Clinical Pharmacology Research Units in Baltimore, Maryland; Berlin, Germany; London, United Kingdom and bioanalytical laboratories in Bloemfontein and Poitiers, France offering more than 500 validated assay methods.

CEMAF SA

Acquisition in 1999
CEMAF S.A., is a Phase I clinical research and bioanalytical laboratory located in Poitiers, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.